A phase I, first in human clinical trial of GR-3027 in healthy volunteers.

Trial Profile

A phase I, first in human clinical trial of GR-3027 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs GR 3027 (Primary)
  • Indications Hepatic encephalopathy
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Most Recent Events

    • 25 Jul 2017 New trial record
    • 03 Nov 2016 According to an Umecrine Cognition media release, the company plans to announce further details and data of the trial at the 9th International Meeting Steroids and Nervous System 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top